Cargando…
Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer
Liposomes (LPs) as promising drug delivery systems are widely applied in cancer therapy. This study aimed to investigate the effect of glypican-1 (GPC1)-targeted and gemcitabine (GEM)-loaded LP [GPC1-LP (GEM)] on cell proliferation and apoptosis in PANC-1s, as well as on orthotopic pancreatic cancer...
Autores principales: | Mu, Yu, Wang, Dezhi, Bie, Liangyu, Luo, Suxia, Mu, Xiaoqian, Zhao, Yanqiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732280/ https://www.ncbi.nlm.nih.gov/pubmed/33035197 http://dx.doi.org/10.18632/aging.103918 |
Ejemplares similares
-
Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines
por: Affram, Kevin, et al.
Publicado: (2015) -
Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives
por: Federico, Cinzia, et al.
Publicado: (2012) -
A Liposomal Gemcitabine, FF-10832, Improves Plasma Stability, Tumor Targeting, and Antitumor Efficacy of Gemcitabine in Pancreatic Cancer Xenograft Models
por: Matsumoto, Takeshi, et al.
Publicado: (2021) -
Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells
por: Celano, Marilena, et al.
Publicado: (2004) -
Glypicans
por: Filmus, Jorge, et al.
Publicado: (2008)